Medical cannabis trust seeks to abandon investment strategy

Greencare Capital trust

Elliot Gulliver-Needham
clock • 1 min read

Greencare Capital trust, which focuses on investing in medical cannabis, CBD and related areas, has said it plans to change its name and investing strategy to pivot away from marijuana.

The £3.7m trust, which would be renamed MaxRS Ventures, would now focus on private equity style investing in technology driven businesses. Four sectors have been identified as areas for investment already: Life sciences, crypto firms, impact investing (environmental and renewables) and retail. A growth incubator or pre-IPO investment philosophy would be adopted, seeking out early stage or undervalued later stage businesses to acquire and later sell through the public markets, with a focus on Europe. The trust said the decision had been made due to the cannabis sector continuing to ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Investment Trusts